Multiple site testing evaluation, Lancing device. ascensia c, Ontour – Bayer HealthCare Ascensia Contour Blood Glucose Monitoring System User Manual
Page 38: Icrolet, Aculance

Multiple Site Testing Evaluation
Forty persons with diabetes, in steady state for glucose,
performed self-capillary blood glucose assays using the
Ascensia C
ONTOUR
System and one reagent lot. A fingerstick
was performed with the Microlet Adjustable Lancing Device.
Samples from the palm, forearm, thigh, and abdomen were
obtained using the Ascensia™ M
ICROLET
V
ACULANCE
®
Lancing
Device. Ascensia C
ONTOUR
results from the multiple sites were
compared to those obtained from the finger. One subject was
unable to obtain a sample from the abdomen. The blood
glucose range from the fingerstick measurements was 49 to
407 mg/dL, with an average of 166 mg/dL. The hematocrit
range was 36 to 52%, with an average of 42%.
34
0
100
200
300
400
500
600
0
100
200
300
400
500
600
0
100
200
300
400
500
600
0
100
200
300
400
500
600
Ascensia
C
ONTOUR
Palm Result (mg/dL)
Ascensia
C
ONTOUR
Fingerstick Result (mg/dL)
Ascensia
C
ONTOUR
Fingerstick Result (mg/dL)
y=x
Ascensia
C
ONTOUR
Forearm Result (mg/dL)
y=x
A. Results from the Palm
B. Results from the Forearm